USANA Health Sciences, Inc. (USNA) Stock

USANA Health Sciences, Inc. (USNA) is a Healthcare stock trading at $13.56 (as of 2026-08-21), with a market capitalization of $250.36M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

USANA Health Sciences, Inc. develops, manufactures, and sells nutritional and personal care products, including vitamin and mineral supplements, targeted optimizers, meal replacement and snack foods, and the Celavive skin care regimen. It also provides materials and online tools to support associates’ marketing and business efforts, selling through channels in the Asia Pacific, Americas, and Europe as well as online.

Understand USANA Health Sciences, Inc.: how it makes money

USANA Health Sciences develops, manufactures, and sells science-based nutritional products, including dietary supplements and meal replacement foods, and personal care items, and it generates sales through a direct-selling model supported by a large base of active customers and active associates.

USANA's profitability depends on sustaining demand for its nutritional and personal care products through its direct-selling network, where active customers and active associates are key indicators of sales momentum.

Business quality (Mixed): We have clear operating indicators (active customers, active associates, and Hiya subscribers), but the provided revenue candidates do not form a clean, mutually exclusive segment breakdown that sums to the stated total revenue.

Valuation: At 36× earnings, USNA trades 114% above the Pharmaceutical Products average (17×). Note: one-time items can distort reported P/E.

Bull case

Large, measurable direct-selling community: The company tracks Active Customers (454,000) and Active Associates (188,000), which can help show whether its selling network is active and generating repeat purchasing.
Additional growth product line with subscriber-style engagement: Hiya is tracked via Active Monthly Subscribers (186,000), suggesting a defined customer base for that product category.
Scale across many markets: USANA reports Number of Global Markets with Company Operations (25), which provides a wider geographic footprint for demand.

Bear case

Profitability is present but not high: Operating margin is 5.5%, so business execution and demand stability matter for maintaining profits.
Potential concentration in certain regions: Active customers are higher in Asia Pacific (326,000) and Greater China (254,000) than in Americas and Europe (78,000), North Asia (45,000), or Southeast Asia Pacific (75,000), so weaker demand in those regions could be a meaningful headwind.
Dependence on direct selling dynamics: Because sales are supported by Active Associates, changes in associate activity could affect the ability to drive customer purchases.

Valuation — source: SEC EDGAR (first-party)
Price	$13.56
Market Cap	$250.36M
EV / EBITDA	2.5
Price / Book	0.48
Price / Sales	0.27
FCF Yield	6.4%
DCF Value (model)	$23.55
DCF Upside vs Price	73.7%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$925.26M
Net Margin	1.2%
Revenue Growth (YoY)	-5.3%
EPS Growth (YoY)	-323.1%
FCF Growth (YoY)	180.4%

Financial Health — source: SEC EDGAR
Altman Z-Score	3.26 (safe)

Valuation vs Sector & Industry
Sector P/E (Healthcare)	21.7
Industry P/E (Pharmaceutical Products)	17.2

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	SUMMIT WEALTH GROUP LLC / CO ($64.65M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Pharmaceutical Products
CEO	Kevin G. Guest
Employees	1,700
Country	US
IPO Date	1994-04-04

Related Companies (Business model: Branded Consumer (CPG, Staples, Beauty, Alcohol, Pet, Nicotine); 8 closest by market cap; US-domiciled)

Data as of 2026-08-21.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.